I. Almendros (Barcelona, Spain), S. Ryan (Dublin 14, Ireland)
Late Breaking Abstract - Differential effect of intermittent hypoxia and sleep fragmentation in the progression of Alzheimer Disease in a mouse model of obstructive sleep apnea
I. Almendros (Barcelona, Spain), M. Menal (Barcelona, Spain), D. Gozal (Chicago, United States of America), A. Colell (Barcelona, Spain), R. Farré (Barcelona, Spain)
|    |
Intermittent hypoxia, the hallmark of sleep apnea, induces HIF-1-dependent mitochondrial dysfunction
S. MOULIN (Grenoble, France), M. Pauly (Grenoble, France), A. Thomas (Los Angeles, United States of America), M. Detrait (Grenoble, France), G. Vial (Grenoble, France), F. Lamarche (Grenoble, France), H. Dubouchaud (Grenoble, France), C. Arnaud (Grenoble, France), D. Godin-Ribuot (Grenoble, France), E. Belaidi-Corsat (Grenoble, France)
| |
Mechanisms involved in the deleterious impact of intermittent hypoxia on ischemic cardiomyopathy.
M. Détrait (Grenoble, France), G. Bourdier (Grenoble, France), S. Moulin (Grenoble, France), E. Belaïdi (Grenoble, France), C. Arnaud (Grenoble, France)
|  |
Transcriptomic analysis identifies a unique, intermittent hypoxia mediated inflammatory profile: evidence from a cross-over randomised CPAP withdrawal trial, with and without supplemental oxygen, in OSA
C. Turnbull (Oxford, United Kingdom), L. Lee (Birmingham, United Kingdom), N. Petousi (Oxford, United Kingdom), J. Stradling (Oxford, United Kingdom)
| |
Acetylsalicylic Acid Prevents Intermittent Hypoxia-Induced Vascular Remodeling in a Murine Model of Sleep Apnea
M. Suarez-Giron (Barcelona, Spain), M. Torres (Barcelona, Spain), J. Montserrat (Barcelona, Spain), C. Picado (Barcelona, Spain), D. Gozal (Chicago, United States of America), A. Castro-Grattoni (Lleida, Spain), M. Sanchez-De-La-Torre (Lleida, Spain), F. Barbé (Lleida, Spain), R. Farré (Barcelona, Spain), I. Almendros (Barcelona, Spain)
| |
The effects of CPAP-withdrawal on cerebral vascular reactivity and brain oxygenation in patients with obstructive sleep apnoea: a randomised-controlled trial.
S. Thiel (Zurich, Switzerland), F. Lettau (Zurich, Switzerland), S. Haile (Zurich, Switzerland), P. Rejmer (Zurich, Switzerland), E. Schwarz (Zurich, Switzerland), A. Stöberl (Zurich, Switzerland), N. Sievi (Zurich, Switzerland), C. Rossi (Zurich, Switzerland), A. Becker (Zurich, Switzerland), A. Boss (Zurich, Switzerland), J. Stradling (Oxford, United Kingdom), M. Kohler (Zurich, Switzerland)
| |
Independent association between obstructive sleep apnea severity and liver stiffness
W. Trzepizur (Angers, France), J. Boursier (Angers, France), M. Le Vaillant (Angers, France), P. Ducluzeau (Tours, France), S. Dubois (Angers, France), S. Henni (Angers, France), P. Abraham (Angers, France), C. Aubé (Angers, France), P. Calès (Angers, France), F. Gagnadoux (Angers, France)
| |
Ticagrelor and central sleep apnea: analysis of VigiBase, the WHO pharmacovigilance database
B. Revol (Grenoble, France), I. Jullian-Desayes (Grenoble, France), R. Tamisier (Grenoble, France), V. Puel (Bordeaux, France), M. Mallaret (Grenoble, France), M. Joyeux-Faure (Grenoble, France), J. Pépin (Grenoble, France)
| |